Spyre Therapeutics (SYRE) Earnings Date, Estimates & Call Transcripts → You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad) Free SYRE Stock Alerts $35.19 +2.17 (+6.57%) (As of 05/9/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateFeb. 29EstimatedActual EPS (Feb. 29) -$2.28 Missed By -$1.80 Consensus EPS (Feb. 29) -$0.48 Get Spyre Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for SYRE and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSYRE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SYRE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Spyre Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.36) EPSNext Year EPS Consensus Estimate: ($2.52) EPSSYRE Earnings Date and InformationSpyre Therapeutics last posted its quarterly earnings data on February 29th, 2024. The reported ($2.28) EPS for the quarter, missing the consensus estimate of ($0.48) by $1.80. Spyre Therapeutics has generated ($75.14) earnings per share over the last year (($75.14) diluted earnings per share). Earnings for Spyre Therapeutics are expected to decrease in the coming year, from ($2.36) to ($2.52) per share. Read More Spyre Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/29/2024Q4 2023($0.48)($2.28)($1.80)($0.51)--11/9/2023Q3 2023($0.44)($3.43)($2.99)$2.48--8/11/2023Q2 2023($4.50)($41.50)($37.00)($26.25)-$0.69 million5/11/2023Q1 2023($4.75)($5.00)($0.25)($5.00)$0.17 million$0.20 million3/2/2023Q4 2022($5.00)($4.50)+$0.50($4.50)$0.17 million$0.17 million11/3/2022Q3 2022($6.00)($4.75)+$1.25($4.75)$0.63 million$0.17 million Get the Latest News and Ratings for SYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($6.50)($6.75)($0.25)($6.75)$1.42 million$0.63 million5/5/2022Q1 2022($8.75)($9.25)($0.50)($9.25)$1.45 million$1.36 million3/8/2022Q4 2021($8.00)($7.75)+$0.25($7.75)$3.07 million$3.64 million11/4/2021Q3 2021($7.25)($7.75)($0.50)($7.75)$1.38 million$1.40 million8/5/2021Q2 2021($4.75)($2.50)+$2.25($2.50)$6.45 million$13.70 million5/10/2021Q1 2021($3.25)($7.00)($3.75)($7.00)-- Spyre Therapeutics Earnings - Frequently Asked Questions When did Spyre Therapeutics announce their last quarterly earnings? Spyre Therapeutics (NASDAQ:SYRE) last announced its quarterly earning data on Thursday, February 29, 2024. Learn more on SYRE's earnings history. Did Spyre Therapeutics beat their earnings estimates last quarter? In the previous quarter, Spyre Therapeutics (NASDAQ:SYRE) missed the analysts' consensus estimate of ($0.48) by $1.80 with a reported earnings per share (EPS) of ($2.28). Learn more on analysts' earnings estimate vs. SYRE's actual earnings. How much revenue does Spyre Therapeutics generate each year? Spyre Therapeutics (NASDAQ:SYRE) has a recorded annual revenue of $890,000.00. How much profit does Spyre Therapeutics generate each year? Spyre Therapeutics (NASDAQ:SYRE) has a recorded net income of -$338.79 million. SYRE has generated -$75.14 earnings per share over the last four quarters. What is Spyre Therapeutics's EPS forecast for next year? Spyre Therapeutics's earnings are expected to decrease from ($2.36) per share to ($2.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Belite Bio Earnings Results Mirum Pharmaceuticals Earnings Results Collegium Pharmaceutical Earnings Results Ironwood Pharmaceuticals Earnings Results Pacira BioSciences Earnings Results Ligand Pharmaceuticals Earnings Results Verona Pharma Earnings Results MannKind Earnings Results AbCellera Biologics Earnings Results Xencor Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:SYRE) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
